Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.6K Hold
322
0.02% 320
2026
Q1
$59K Hold
322
0.02% 328
2025
Q4
$56.7K Sell
322
-370
-53% -$60.4K 0.02% 329
2025
Q3
$96.9K Hold
692
0.03% 272
2025
Q2
$86.9K Hold
692
0.03% 281
2025
Q1
$94.7K Hold
692
0.03% 268
2024
Q4
$106K Sell
692
-200
-22% -$33.7K 0.04% 246
2024
Q3
$173K Buy
892
+160
+22% +$33.5K 0.06% 200
2024
Q2
$170K Sell
732
-100
-12% -$21.7K 0.07% 196
2024
Q1
$179K Hold
832
0.08% 191
2023
Q4
$215K Sell
832
-118
-12% -$29K 0.11% 164
2023
Q3
$244K Buy
950
+5
+0.5% +$1.34K 0.13% 147
2023
Q2
$269K Buy
945
+30
+3% +$8.93K 0.15% 137
2023
Q1
$254K Sell
915
-30
-3% -$8.3K 0.15% 143
2022
Q4
$262K Hold
945
0.16% 138
2022
Q3
$252K Buy
945
+170
+22% +$36.1K 0.18% 124
2022
Q2
$158K Buy
775
+70
+10% +$14.3K 0.11% 162
2022
Q1
$149K Buy
705
+195
+38% +$42.4K 0.09% 181
2021
Q4
$122K Buy
+510
New +$131K 0.08% 208

Other funds holding BIIB

City State Bank's BIIB Position: Q2 2026 in Review

City State Bank held its Biogen (BIIB) position steady in Q2 2026 at 322 shares worth $69.6K. The position accounts for 0.02% of the portfolio, ranked #320.

City State Bank first reported a position in BIIB in Q4 2021 and has held it in 19 quarters since. The position peaked at $269K in Q2 2023. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • City State Bank held 322 shares of Biogen worth $69.6K as of Q2 2026.
  • City State Bank left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.02% of City State Bank's portfolio in Q2 2026, its #320 holding.
  • City State Bank first reported a position in Biogen in Q4 2021 and has held it in 19 quarters since.
  • City State Bank's Biogen position peaked at $269K in Q2 2023.
  • 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.